Catalent, Inc. (New York Stock Exchange:CTLT)

About the company

Catalent, Inc. is a holding company, which engages in the provision of delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. It operates through the following segments: Softgel Technologies; Biologics and Specialty Drug Delivery; Oral Drug Delivery; and Clinical Supply Services. The Softgel Technologies segment formulate, develop, and manufacture services for soft capsules. The Biologics and Specialty Drug Delivery segment develops and manufacture services for blow-fill-seal unit doses, prefilled syringes, vials, and cartridges; analytical development and testing services for large molecules; inhaled products for delivery via metered dose inhalers, dry powder inhalers, and intra-nasal sprays. The Oral Drug Delivery segment focuses in the formulation development and manufacturing technologies, and related solutions including: clinical development and commercial manufacturing of a range of oral dose forms, including proprietary fast-dissolve Zydis tablets and both conventional immediate and controlled release tablets, capsules, and sachet products. The Clinical Supply Services segment includes packaging, labeling, storage, distribution, and inventory management for drugs and biologics in clinical trials. The company was founded in April 2007 and is headquartered in Somerset, NJ.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

12300

CEO

John R. Chiminski

Exchange

New York Stock Exchange

Website

http://www.catalent.com

$3B

Total Revenue

12K

Employees

$11B

Market Capitalization

104.47

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$905M

Operating Margin (in %)

Total operating margin

$342M

Net Margin (in %)

Total net margin

$104M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12030.90 1376.00 5.13 18.97 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7562.40 4837.00 1.30 51.59 3.02
Bausch Health Cos., Inc. BHC 6505.79 8597.00 9.08 -3.44 -21.96
Jazz Pharmaceuticals Plc JAZZ 6200.46 2188.00 2.14 22.66 12.81
United Therapeutics Corp. UTHR 5099.80 1443.00 1.77 9.84 36.59
MyoKardia, Inc. MYOK 4325.84 34.00 12.57 -13.95 -201.73
Axsome Therapeutics, Inc. AXSM 2963.17 None 20.11 -32.94 None
Pacira Biosciences, Inc. PCRX 2275.14 435.00 6.10 -5417.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2181.92 9.00 2.56 -3.37 -413.06
Corcept Therapeutics, Inc. CORT 2023.98 335.00 4.65 19.07 31.64
Prestige Consumer Healthcare, Inc. PBH 1850.28 963.00 1.56 13.05 14.77
Revolution Medicines, Inc. RVMD 1738.14 48.00 4.51 -24.55 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1640.55 0.00 4.38 -16.06 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1595.90 440.00 -22.59 18.82 19.14
Innoviva, Inc. INVA 1580.87 285.00 3.74 8.18 66.41
Intercept Pharmaceuticals, Inc. ICPT 1475.20 272.00 -43.90 -4.30 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Zogenix, Inc. ZGNX 1246.21 5.00 3.40 -2.93 -241.62
Revance Therapeutics, Inc. RVNC 1230.46 0.00 4.86 -6.59 41.82
Theravance Biopharma, Inc. TBPH 1136.58 88.00 -7.98 -4.61 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1056.44 327.00 2.64 20.73 15.90
Endo International Plc ENDP 825.36 3014.00 -1.13 -2.94 -9.09
BellRing Brands, Inc. BRBR 771.22 954.00 -0.42 5.85 13.98
Assembly Biosciences, Inc. ASMB 693.39 16.00 3.11 -6.97 -601.75
Eagle Pharmaceuticals, Inc. EGRX 671.16 192.00 3.61 266.33 1.29
Aerie Pharmaceuticals, Inc. AERI 641.70 79.00 5.09 -3.17 -252.92
Collegium Pharmaceutical, Inc. COLL 593.64 299.00 4.25 -45.95 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 537.14 119.00 5.23 12.24 36.09
Anika Therapeutics, Inc. ANIK 505.26 125.00 1.75 18.23 22.73
Intersect ENT, Inc. XENT 445.76 102.00 4.21 -8.93 -48.61
BioDelivery Sciences International, Inc. BDSI 401.12 130.00 5.74 -54.50 -5.01
ANI Pharmaceuticals, Inc. ANIP 367.56 203.00 1.88 -235.62 -0.67
Albireo Pharma, Inc. ALBO 332.41 11.00 3.38 -4.35 -730.55
MEI Pharma, Inc. MEIP 284.69 5.00 4.90 -7.30 -539.48
Mallinckrodt Plc MNK 209.16 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 163.43 None 2.66 -7.91 None
Marinus Pharmaceuticals, Inc. MRNS 161.60 0.00 6.26 -2.40 None
Cerecor, Inc. CERC 120.75 7.00 7.72 -5.36 -429.22
Ampio Pharmaceuticals, Inc. AMPE 95.81 1.00 67.00 -5.15 None
CTI BioPharma Corp. CTIC 91.45 3.00 4.08 -2.21 -111.83
Evoke Pharma, Inc. EVOK 89.28 None 31.00 -13.29 None
AcelRx Pharmaceuticals, Inc. ACRX 84.80 2.00 -1.56 -1.51 -644.25
Zynerba Pharmaceuticals, Inc. ZYNE 74.75 0.00 1.23 -2.08 -699.94
Adamas Pharmaceuticals, Inc. ADMS 71.68 57.00 -4.57 -0.77 -160.44
Aclaris Therapeutics, Inc. ACRS 68.88 4.00 1.21 -0.50 None
Oramed Pharmaceuticals, Inc. ORMP 60.30 3.00 4.86 -4.72 -464.15
Cassava Sciences, Inc. SAVA 59.28 41.00 3.12 -13.00 76.71
SCYNEXIS, Inc. SCYX 48.89 0.00 10.27 -1.26 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 48.60 47.00 0.99 -10.80 -9.59
Natural Alternatives International, Inc. NAII 47.11 114.00 0.65 -12.46 -3.19
Lipocine, Inc. LPCN 43.50 0.00 10.36 -2.90 None
IsoRay, Inc. ISR 42.88 9.00 8.00 -12.80 -36.08
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 27.00 0.00 -2.59 -2.86 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.24 3.00 2.39 -1.62 -264.21
Regulus Therapeutics, Inc. RGLS 18.15 0.00 1.60 -0.85 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.66 None 1.37 -0.25 None
VIVUS, Inc. VVUS 8.88 73.00 -0.20 -0.30 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.37 19.00 1.01 -2.04 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.76 None 1.80 -0.48 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.27 None 1.07 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Best in Tech 2020: Catalent's $1.2 billion acquisition of Paragon Bioservices

12d ago, source: The Business Journals

Since being acquired by Catalent, Baltimore-based vaccine and gene therapy maker Paragon Bioservices has ramped up hiring and ...

Moderna, Catalent Collaborate On Coronavirus Vaccine Manufacturing Capacity

12d ago, source: YAHOO!

Moderna Inc (NASDAQ: MRNA), a frontrunner in the COVID-19 vaccine race, announced a manufacturing collaboration agreement ...

Moderna Collaborates With Catalent for Coronavirus Vaccine

11d ago, source: YAHOO!

Moderna (MRNA) teams up with Catalent for large-scale, commercial fill-finish manufacturing of the former's mRNA-based ...

Moderna picks drugmaker Catalent to manufacture potential COVID-19 vaccine

13d ago, source: YAHOO!

Under the deal, Catalent will provide manufacturing services for an initial 100 million doses starting in the third quarter ...

Moderna names Catalent as manufacturing partner for potential COVID-19 vaccine

13d ago, source: Nasdaq

Moderna Inc said on Thursday it has partnered with contract drugmaker Catalent Inc to produce 100 million doses of its ...

Moderna eyes third quarter for first doses of potential COVID-19 vaccine with Catalent deal

12d ago, source: Reuters

Moderna Inc said on Thursday it was partnering with contract drugmaker Catalent Inc to prepare an initial 100 million doses ...

Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate

12d ago, source: YAHOO!

Moderna and Catalent announce collaboration for fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate.



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.